These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10369113)

  • 1. Endothelin-1- and endothelin-receptors in lung biopsies of patients with pulmonary hypertension due to congenital heart disease.
    Lutz J; Gorenflo M; Habighorst M; Vogel M; Lange PE; Hocher B
    Clin Chem Lab Med; 1999 Apr; 37(4):423-8. PubMed ID: 10369113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and pathological implication of transforming growth factor-beta1 mRNA and endothelin-1 mRNA in intraacinar pulmonary arterioles of congenital heart disease accompanied with pulmonary hypertension].
    Gao BH; Yao RX; Zhao ZG; Xie LW; Xiang RL; Hu XT; Wang ZM
    Zhonghua Bing Li Xue Za Zhi; 2005 Mar; 34(3):159-62. PubMed ID: 15938827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease.
    Huang H; Zhang P; Wang Z; Tang F; Jiang Z
    Circ J; 2011; 75(6):1463-71. PubMed ID: 21498912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and role of urotensin II on the lung of patients with pulmonary hypertension with congenital heart disease].
    Rong X; Wu HP; Qiu HX; Ren Y; Zhang YH; Chen Q; Wu RZ; Hu XT
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):689-91. PubMed ID: 23158820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma endothelin 1 concentrations in children with congenital heart defects.
    Jia B; Zhang S; Chen Z; Li Z; Li X; Hui W; Ye M
    Minerva Pediatr; 1998 Apr; 50(4):99-103. PubMed ID: 9808961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects.
    Hiramatsu T; Imai Y; Takanashi Y; Hoshino S; Yashima M; Tanaka SA; Chang D; Nakazawa M
    Ann Thorac Surg; 1997 Mar; 63(3):648-52. PubMed ID: 9066378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changes of plasma endothelin concentration and its clinical significance in pulmonary hypertension associated with congenital heart defects].
    Zhang S; Qi S; Shen X; Zhou S; Jin S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):425-7. PubMed ID: 10073026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No redistribution of lung blood flow by inhaled nitric oxide in endotoxemic piglets pretreated with an endothelin receptor antagonist.
    Trachsel S; Hambraeus-Jonzon K; Bergquist M; Martijn C; Chen L; Hedenstierna G
    J Appl Physiol (1985); 2015 Mar; 118(6):768-75. PubMed ID: 25549764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension.
    Shao D; Park JE; Wort SJ
    Pharmacol Res; 2011 Jun; 63(6):504-11. PubMed ID: 21419223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease.
    Komai H; Adatia IT; Elliott MJ; de Leval MR; Haworth SG
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):473-8. PubMed ID: 8361190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of the levels of adrenomedulin, endothelin-1 and nitric oxide in children with pulmonary hypertension secondary to congenital heart disease].
    Chu MP; Wu RZ; Ren Y
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):779-80. PubMed ID: 18211765
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelin-1 may play an important role in the Fontan circulation.
    Aoki M; Hirono K; Higuma T; Suzuki Y; Nakayama K; Ichida F; Origasa H; Nishida N; Imura J; Emoto N; Yoshimura N
    Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):480-486. PubMed ID: 29177420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation.
    Yoshibayashi M; Nishioka K; Nakao K; Saito Y; Matsumura M; Ueda T; Temma S; Shirakami G; Imura H; Mikawa H
    Circulation; 1991 Dec; 84(6):2280-5. PubMed ID: 1959183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.
    Abraham DJ; Vancheeswaran R; Dashwood MR; Rajkumar VS; Pantelides P; Xu SW; du Bois RM; Black CM
    Am J Pathol; 1997 Sep; 151(3):831-41. PubMed ID: 9284832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
    Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow.
    Vincent JA; Ross RD; Kassab J; Hsu JM; Pinsky WW
    Am J Cardiol; 1993 May; 71(13):1204-7. PubMed ID: 8480647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice.
    Hocher B; Schwarz A; Fagan KA; Thöne-Reineke C; El-Hag K; Kusserow H; Elitok S; Bauer C; Neumayer HH; Rodman DM; Theuring F
    Am J Respir Cell Mol Biol; 2000 Jul; 23(1):19-26. PubMed ID: 10873149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes of endothelin-1, nitric oxide, and cyclic GMP in patients with congenital heart disease.
    Bando K; Vijayaraghavan P; Turrentine MW; Sharp TG; Ensing GJ; Sekine Y; Szekely L; Morelock RJ; Brown JW
    Circulation; 1997 Nov; 96(9 Suppl):II-346-51. PubMed ID: 9386122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.